A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

After a record-breaking year for startup IPOs in 2025, the momentum for new-age tech companies going for public listings appears even stronger in 2026 Twenty eight startups have already filed their ...

Five years ago, I created Version 1.0 of the breakdown of the scholarship situation at WVU and the outgoing (and incoming) transfers. With the season now over for the Mountaineers, it's time to revamp ...